Hollencrest Capital Management’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Hollencrest Capital Management’s Portfolio VAXX Stock Details VAXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-20,000	Closed	-$17K	–	1152
2023 Q4	$17K	Hold	20,000	–	–	﹤0.01%	660
2023 Q3	$27.4K	Hold	20,000	–	–	﹤0.01%	565
2023 Q2	$50.4K	Hold	20,000	–	–	0.01%	494
2023 Q1	$45.4K	Hold	20,000	–	–	﹤0.01%	495
2022 Q4	$28K	Hold	20,000	–	–	﹤0.01%	547
2022 Q3	$40K	Hold	20,000	–	–	0.01%	297
2022 Q2	$31K	Buy	+20,000	New	+$75.6K	﹤0.01%	328

Other funds holding VAXX

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

SAS

Stelac Advisory Services New York $494M AUM 23.25% 1-Year Est. Return

Hollencrest Capital Management's VAXX Position: Q1 2024 in Review

Hollencrest Capital Management sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q1 2024, closing a stake of 20,000 shares — an estimated $17K sold.

Hollencrest Capital Management first reported a position in VAXX in Q2 2022 and held it in 7 quarters. The position peaked at $50.4K in Q2 2023. 58 funds tracked by Wall St. Rank hold VAXX as of Q1 2024.

Hollencrest Capital Management reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Hollencrest Capital Management sold 20,000 Vaxxinity, Inc. Class A Common Stock shares in Q1 2024, an estimated $17K.
Hollencrest Capital Management first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2022 and held it in 7 quarters.
Hollencrest Capital Management's Vaxxinity, Inc. Class A Common Stock position peaked at $50.4K in Q2 2023.
58 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q1 2024.

Based on Hollencrest Capital Management's 13F filing for Q1 2024, filed 1 May 2024.